Fatigue, depression and chronic hepatitis C infection

Psychological Medicine

Volumn 32, Issue 1, 2002, Pages 1-10

  Wessely, Simon ^a,b   Pariante, Carmine ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE MARKER; EXERCISE; FATIGUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MEDICAL SPECIALIST; METABOLIC DISORDER; PATIENT REFERRAL; PHYSICAL DISEASE; REVIEW; RISK FACTOR;

EID: 0036133497     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291701004615     Document Type: Review

References (70)

1. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
2. Post-infection fatigue syndrome following Q fever
3. Musculoskeletal pain and fatigue are associated with chronic hepatitis C
4. Ireland's infected blood products inquiry begins
5. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
6. Persistent hepatitis C viraemia without liver disease
7. Extrahepatic manifestations in 1614 patients with chronic hepatitis C
8. Fatigue in primary biliary cirrhosis
9. The clinician's illusion
10. The Health and Lifestyle Survey
11. Chronic fatigue syndrome: Lack of association with hepatitis C virus infection
12. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation
13. Quality of life during chronic hepatitis C: Study of 466 patients before treatment
14. Fatigue, depression and disability in patients with chronic hepatitis C
15. Fatigue in HIV illness: Relationship to depression, physical limitations and disability
16. Hepatitis C virus infection: Quality of life and side effects of treatment
17. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
18. The chronic fatigue syndrome: A comprehensive approach to its definition and study
19. Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with chronic hepatitis B
20. Serum cytokine values and fatigue in chronic hepatitis C infection
21. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection
22. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis
23. The prevalence of rheumatological disease in those infected with hepatitis C virus (HCV)
24. Hepatitis C: The clinical spectrum of disease
25. Serum levels of cytokines in hepatitis C-related liver disease: A longitudinal study
26. Is fatigue a long term side effect of breast cancer treatment?
27. Hepatitis C and depression in drug users
28. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis
29. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
30. Sickness behavior as a new target for drug development
31. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
32. Role of body composition, resting energy expenditure, and exercise tolerance in fatigue among patients with chronic hepatitis C
33. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
34. Hodgkin's disease survivors more fatigued than the general population
35. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus
36. Relationship between interleukin-6 activity, acute phase proteins, and the function of the hypothalamic-pituitary-adrenal axis in severe depression
37. Fatigue in patients with chronic hepatitis C
38. Long term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-A therapy
39. Sero-epidemiology of chronic fatigue syndrome: A case control study
40. Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis
41. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis
42. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients
43. Fatigue assessment in patients with hepatitis C
44. In the eye of the beholder: Assessment of health related quality of life
45. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders
46. Quality of life in long-term survivors after liver transplantation: Impact of recurrent viral hepatitis C virus hepatitis
47. A population based study of fatigue and psychological distress
48. Fatigue in patients with chronic hepatitis C is associated with age, female gender, alcohol consumption and fibrosis stage
49. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
50. Fibromyalgia-associated hepatitis C virus infection
51. The impact of the diagnosis of hepatitis C virus on quality of life
52. Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic and histologic features
53. Assessment of quality of life in patients with chronic hepatitis C using a range of subjective fatigue assessment tools
54. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)
55. Vulnerability to psychologic distress and depression in patients with end-stage disease due to hepatitis C virus
56. Psychiatric disorders in hepatitis C virus related chronic liver disease
57. Serum levels of cytokines in chronic liver diseases
58. Clinical outcomes after transfusion associated hepatitis C
59. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin 6 and tumor necrosis factor in patients with acute viral hepatitis
60. Fatigue in lupus is not correlated with disease activity
61. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response
62. Risk of fatigue and chronic fatigue syndrome in association with patients with hepatitis C viral infection in patients with bleeding disorders
63. Viruses and fatigue: The current status of chronic fatigue syndrome
64. The epidemiology of chronic fatigue syndrome
65. Post-infectious fatigue: A prospective study in primary care
66. Chronic Fatigue and its Syndromes
67. The prevalence and meaning of fatigue in rheumatic disease
68. Hepatitis C and depression
69. Hepatitis C, interferon alfa, and depression
70. Anxiety, not depression, is the primary emotional disturbance in patients with chronic hepatitis